It is indicated for the prophylaxis and chronic treatment of asthma in adults and pediatric patients 12 months of age and older.
It is indicated for prevention of exercise-induced bronchoconstriction in patients 6 years of age and older.
It is indicated for the relief of symptoms of seasonal allergic rhinitis in patients 2 years of age and older and for perennial allergic rhinitis in patients 6 months of age and older.
Dosage (For Asthma):
Adults (15 years & older): one 10 mg tablet.
Pediatric patients (6 to 14 years): one 5 mg tablet.
Pediatric patients (2 to 5 years): one 4 mg tablet.
Pediatric patients (12 to 23 months): one sachet of 4 mg oral granules.
Following information see from leaflet inside the pack:
Mechanism of action, Pharmacokinetics, Administration, Dosing consideration in special populations, contraindications, warinings and precautions, adverse ractions, drug interations, use in special population, overdosage.
